2LG5
| |
5LCS
| |
6CS9
| Crystal structure of human beta-defensin 2 in complex with PIP2 | Descriptor: | Beta-defensin 4A, [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate | Authors: | Jarva, M, Phan, K, Lay, F.T, Humble, C, Hulett, M, Kvansakul, M. | Deposit date: | 2018-03-20 | Release date: | 2018-07-25 | Last modified: | 2023-10-04 | Method: | X-RAY DIFFRACTION (1.85 Å) | Cite: | Human beta-defensin 2 killsCandida albicansthrough phosphatidylinositol 4,5-bisphosphate-mediated membrane permeabilization. Sci Adv, 4, 2018
|
|
6M56
| |
7LZL
| |
7T9Q
| Crystal structure of Crocodile defensin CpoBD13 | Descriptor: | 1,2-ETHANEDIOL, CITRATE ANION, CpoBD13 | Authors: | Kvansakul, M, Williams, S, Hulett, M.D. | Deposit date: | 2021-12-19 | Release date: | 2023-01-18 | Last modified: | 2023-10-25 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Crocodile defensin (CpoBD13) antifungal activity via pH-dependent phospholipid targeting and membrane disruption. Nat Commun, 14, 2023
|
|
7T9R
| Crystal structure of Crocodile defensin CpoBD13:phosphatidic acid complex | Descriptor: | (R)-2-(FORMYLOXY)-3-(PHOSPHONOOXY)PROPYL PENTANOATE, 1,2-ETHANEDIOL, CpoBD13, ... | Authors: | Kvansakul, M, Williams, S, Hulett, M.D. | Deposit date: | 2021-12-19 | Release date: | 2023-01-18 | Last modified: | 2023-10-25 | Method: | X-RAY DIFFRACTION (1.45 Å) | Cite: | Crocodile defensin (CpoBD13) antifungal activity via pH-dependent phospholipid targeting and membrane disruption. Nat Commun, 14, 2023
|
|